Drug monitoring of mycophenolic acid in the early period after renal transplantation.
Krumme
B
B
Department of University Hospital Freiburg, Germany.
Wollenberg
K
K
Kirste
G
G
Schollmeyer
P
P
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000097:blood* / Q000627:therapeutic use; D011183:Postoperative Complications / Q000453:epidemiology; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors; D014552:Urinary Tract Infections / Q000453:epidemiology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid